Abstract-To determine whether opioid receptors (ORs) are involved in the delayed cardioprotection of ischemic preconditioning (IP), the effect of severe metabolic inhibition (MI) with a glucose-free buffer that contained sodium cyanide and 2-deoxy-D-glucose on the viability of isolated rat ventricular myocytes was first determined 20 hours after preconditioning with a sublethal metabolic inhibition (MIP) with a glucose-free buffer that contained 2-deoxy-D-glucose and lactate for 30 minutes in the presence of OR antagonists. With the use of trypan blue exclusion as an index of cell viability, severe MI killed Ͼ60% of the cells and the value increased significantly after MIP. In the presence of 5ϫ10
I
schemic preconditioning (IP), which is defined as previous exposure to transient myocardial ischemia, provides protection to subsequent severe insults in the heart. Early studies show that the protection occurs immediately and wanes within 1 to 2 hours. 1 This is called classic IP. More recently, it was found that IP can also trigger a delayed cardioprotection 12 to 72 hours later, which is called second window of IP. 2 The longer cardioprotection in the second window may be more useful clinically. In addition to ischemia, preconditioning with other insults such as hypoxia, 3 metabolic inhibition (MI), 4 and high Ca 2ϩ5 also provide protection against subsequent severe ischemic insults, a cross-tolerance phenomenon.
Opioid receptors (ORs) have been suggested to be involved in immediate 6, 7 and delayed 8, 9 cardioprotection of IP. More recent studies show that the ␦-receptor may be involved. 10 A previous receptor binding study showed that IP, which elevated the ventricular fibrillation threshold, 11 reduced the binding affinity of the -OR, the predominant OR in the heart, 12, 13 which suggests that the -OR may also be involved in cardioprotection of IP. However, findings from a receptor binding study are not conclusive.
Therefore, the purpose of the present study was to determine whether any subtypes of OR are involved in the cardioprotection of IP, and, if so, the possible mechanisms involved. We concentrated on delayed cardioprotection for 2 reasons. First, the longer duration of protection was considered more useful clinically. Second, the mechanisms of delayed cardioprotection are less understood. We adopted a procedure used by Nayeem and colleagues 14 who preconditioned isolated ventricular myocytes with mild MI (MIP), which produced a delayed cardioprotection similar to that of IP. An advantage of the isolated myocyte model was that we not only could study the viability and functional status of the cells but also the intracellular events such as the intracellular Ca 2ϩ ([Ca   2ϩ ] i ) response, which provides information on [Ca 2ϩ ] i homeostasis in the heart. In the present study, we determined the viability, [Ca 2ϩ ] i , and contraction of the ventricular myocytes that were subjected to MIP with or without the blockade or activation of OR subtypes. We also determined the cardioprotection of MIP and pretreatment with an opioid agonist when protein kinase C (PKC), known to mediate the cardioprotection of IP 15 and the effects of OR stimulation, 16 ,17 was blocked. The results of the present study show that -OR mediates the cardioprotection of MIP and that both [Ca 2ϩ ] i and PKC may be involved in the delayed cardioprotection of MIP and pretreatment with a -opioid agonist.
Materials and Methods

Isolation and Culture of Rat Ventricular Myocytes
Myocytes were isolated from hearts of adult Sprague-Dawley rats with a collagenase method described previously. 18 The level of viable myocytes, as indicated by trypan blue exclusion, was Ϸ76% of total cells. The cells were incubated in a CO 2 incubator (95% air/5% CO 2 , 28°C) for 1 to 28 hours in culture dishes in 5 mL of MEM that contained 1ϫ10 Ϫ3 mol/L Ca 2ϩ , 0.2% BSA, 1ϫ10 Ϫ8 mol/L insulin, 100 U/mL of penicillin G, and 100 g/mL of streptomycin according to the method of Sheng and colleagues. 19 The percentages of nonblue cells were 70.7%, 69.7%, 64.8%, 62.1%, and 51.5% after 1, 6, 16, 20 , and 28 hours of incubation in normal medium, respectively.
Experimental Protocol
After the ventricular myocytes had been separated, they were allowed to stabilize for 30 minutes before the experiment started. We used the procedures described by Nayeem and colleagues 14 ( Figure 1A ). Cells were subjected either to MIP with a glucose-free Krebs buffer (pH 6.6) that contained 2ϫ10 Ϫ2 mol/L lactate and 1ϫ10 Ϫ2 mol/L 2-deoxy-Dglucose (2-DOG), an inhibitor of glycolysis, or to pretreatment with an OR agonist for 30 minutes in the presence of an OR-antagonist (5 minutes before and throughout MIP) or an inhibitor of PKC (1 hour before MIP began). In the control groups, the cells were subjected to pretreatment with vehicle (VP) for 30 minutes or an OR antagonist or PKC inhibitor alone for 35 minutes or 1 hour, respectively. Myocytes were washed several times after pretreatment to ensure that the cells were free of any drug. They were then incubated in normal MEM for 20 hours, except in the experiments that involved time course study, in which the cells were cultured for 1, 6, 16, 20 , and 28 hours ( Figure 3A) . Finally, the cells were subjected to severe MI for 5 minutes with 1.5ϫ10
Ϫ3 mol/L sodium cyanide and 2ϫ10 Ϫ2 mol/L 2-DOG, followed by washout and replacement with normal solution reperfusion.
Myocytes incubated for 20 hours were more sensitive to severe MI than the fresh cells as indicated by the fact that only 22% of the cells were alive after 20 hours of culture compared with 43% in the fresh cells at 10 minutes into reperfusion after severe MI.
Trypan Blue Exclusion and Cell Morphology
Trypan blue exclusion was used as an index of the viability of the myocytes. 3, 20 After the live cells were incubated with 0.4% trypan Ϫ6 mol/L each, which was administered 5 minutes before and throughout MIP. The control groups were vehicle (VP), CTOP (CTOP-P), naltrindole (NTD-P), or nor-BNI (NB-P) alone at 5ϫ10
Ϫ6 mol/L without MIP. The cells were then washed several times before they were incubated in a MEM for 20 hours and then subjected to severe MI for 5 minutes. This was followed by washing and replacement with normal solution reperfusion (RE). Cell morphology was determined by microscopic examination. 3,4 Both rod-shaped (length/width ratio, Ͼ3:1) and square (length/width ratio, Ͻ3:1, Ͼ1:1) cells were examined. Only the results from rod-shaped cells were presented, because the conclusion remained the same with or without the results from square cells. Approximately 100 cells in each of 5 cultures were determined for each group.
Measurement of Contraction and Electrically Induced [Ca 2؉ ] i Transient in the Single Ventricular Myocyte
Myocytes incubated for 20 hours after preconditioning/pretreatment were placed in a chamber and superfused with a bicarbonate Krebs solution that contained (mmol/L) 118 NaCl, ] i transient was determined by a spectrofluorometric method described previously. 21, 22 The fluorescence ratio of 340 nm (F340) over 380 nm (F380) was used as an index of [Ca 2ϩ ] i because changes in the fluorescence ratio were considered to accurately reflect the fluctuations in the cytosolic Ca 2ϩ of the contraction-relaxation cycle. 23
Drugs and Chemicals
CTOP, naltrindole, and nor-binaltorphimine (nor-BNI), selective antagonists of -, 24 ␦-, 25 and -OR, 26, 27 respectively; U50,488H, a selective -OR agonist 28, 29 ; and chelerythrine, an inhibitor of PKC, 30 were used. In the present study, the concentration range of U50,488H was 3ϫ10 Ϫ6 to 1ϫ10 Ϫ4 mol/L because, at a similar range, this drug has been shown to activate the phospholipase C/Ca 2ϩ pathway, 31 which leads to the mobilization of Ca 2ϩ from its intracellular store. 17, 19, 32 The effects were antagonized by 5ϫ10
Ϫ6 mol/L nor-BNI, 22, 31, 33 which itself had no effect. The concentrations of naltrindole, 34, 35 CTOP, 36,37 nor-BNI, 22, 31, 33 and chelerythrine 38, 39 used in this study were based on previous studies, which showed that at the concentrations used, the OR antagonists and the PKC inhibitor, Ϫ6 mol/L nor-BNI. The experimental procedure was the same as that described in Figure  1A . For UP, the agonist was administered for 30 minutes after the ventricular myocytes were isolated and stabilized. Nor-BNI was administered 5 minutes before and again during MIP and UP. VP indicates vehicle control; NB-P, nor-BNI only; NBϩMIP, MIP in the presence of nor-BNI; and NBϩUP, UP in the presence of nor-BNI. Values, presented as nonblue (upper) or rod-shaped (lower) cells per total myocytes counted, are meanϮSEM; nϭ8 cultures of Ϸ200 cells each for viability experiments and nϭ5 cultures of Ϸ100 cells each for morphology experiments. *PϽ0.05, **PϽ0.01, ***PϽ0.001 vs VP; ##PϽ0.01 and ###PϽ0.001 vs corresponding groups without nor-BNI.
which themselves had no effect at all, blocked the effects of the respective OR agonists and PKC.
U50,488H, fura-2/AM, type 1 collagenase, sodium cyanide, 2-DOG, chelerythrine, and trypan blue dye were purchased from Sigma Chemical Co. Nor-BNI was purchased from Tocris Cookson Ltd, and naltrindole and CTOP were purchased from Research Biochemicals International. All chemicals were dissolved in distilled water except chelerythrine and fura-2/AM, which were dissolved in DMSO at a final concentration Ͻ0.1%, at which no effect was observed.
Statistical Analysis
Data were expressed as meanϮSEM. One-way ANOVA was used to determine the differences among the multiple groups. For analysis of drug effects, the nonparametric Kruskal-Wallis test was used. PϽ0.05 was considered statistically significant.
Results
Effects of MIP on Trypan Blue Exclusion in Isolated Ventricular Myocytes in the Presence of OR Antagonists
This series of experiments was undertaken to determine which of the 3 OR subtypes may be involved in the mediation of delayed cardioprotection of MIP ( Figure 1A) . After 20 hours of incubation followed by 5 minutes of severe MI, the percentage of the nonblue cells per the total number of cells at 10 minutes into reperfusion in the MIP group was 38%; this was significantly higher than the 22% found in the VP group ( Figure 1B) . In the presence of nor-BNI, the nonblue cells were 25% of total cells, which was significantly lower than 38% in the MIP group. On the other hand, in the presence of CTOP or naltrindole, the effect of MIP was not attenuated.
Effects of Pretreatment With U50,488H on the Viability of Ventricular Myocytes
This second series of experiments was designed to determine whether pretreatment with U50,488H (UP) produced cardioprotection similar to that observed with MIP. The same experimental procedure as in the first series of experiments was used except that the ventricular myocytes were pretreated with 3ϫ10
Ϫ6 to 1ϫ10 Ϫ4 mol/L U50,488H for 30 minutes. The percentage of nonblue cells at 10 minutes into reperfusion was significantly higher than that of the VP group when U50,488H was at 1ϫ10 Ϫ5 mol/L, and the maximum response was reached when the concentration of U50,488H was 3ϫ10 Ϫ5 mol/L (Figure 2A) . We used the concentration 3ϫ10
Ϫ5 mol/L for all experiments. EC 50 was 3.311ϫ10
Ϫ6 mol/L. In the presence of 5ϫ10 Ϫ6 mol/L nor-BNI, which in itself had no effect, the percentages of the nonblue cells in both MIP and UP were significantly reduced ( Figure 2B, top) .
To compare the responses in terms of myocyte viability and cell shape, the rod-shaped cells were counted 10 minutes into reperfusion. Only 11% of the cells were rod-shaped in the VP group, although the percentage of rod-shaped cells increased to 30% and 24% in the MIP and UP groups, respectively ( Figure 2B, bottom) . Nor-BNI significantly attenuated (19%) and completely abolished (12%) the effects of MIP and UP, respectively ( Figure 2B, bottom) .
To study the time course of cardioprotection of UP, we determined the viability of myocytes incubated for different periods of time (1, 6, 16, 20 , and 28 hours) after 30 minutes of UP ( Figure 3A) . The nonblue cells that were found 10 minutes into reperfusion after 1 hour of incubation and severe MI, composed only 35% of the total cells in the VP group. Myocyte viability decreased as the incubation time increased.
A plateau of Ϸ20% was reached at 16 hours. The viability of the UP groups was significantly higher than that in the corresponding VP groups at 1, 16, and 20 hours, with the greatest difference at the 20-hour point (36% versus 22%; Figure 3B ).
Effects of MIP and UP on Contraction and Electrically Induced [Ca 2؉ ] i Transient in Single Surviving Myocytes
To determine the functional status of the cells after MIP and UP, both contraction and electrically induced [Ca 2ϩ ] i transient during reperfusion and after 20 hours of incubation and severe MI were determined. Measurements were made at 5 minutes into reperfusion because the difference in contraction among the groups at this time was most obvious as shown in the previous 40 and present studies. In the VP group, the amplitude of contraction was only 13% of baseline (100%; Figure 4A , top, and 4B). The amplitudes in the MIP and UP groups were significantly increased; MIP was 65% and UP was 42% ( Figure 4A and 4B ) of baseline. When the myocytes were subjected to MIP or UP in the presence of 5ϫ10 Ϫ6 mol/L nor-BNI, which itself had no effect, the amplitude returned to the level of the VP group ( Figure 4B) .
Similar to the measurement of contractility, the electrically induced [Ca 2ϩ ] i transient was also measured 5 minutes into reperfusion. In the same manner as the response in contraction, the [Ca 2ϩ ] i transient was significantly reduced by severe MI in the VP group ( Figure 5A, top) , which was in agreement with the previous study. 41 MIP (Figure 5A , middle, and 5B) and UP ( Figure 5A , bottom, and 5B) significantly attenuated the effects of severe MI. The effects of MIP and UP ( Figure  5B ) were significantly attenuated and completely abolished with 5ϫ10
Ϫ6 mol/L nor-BNI, which itself had no effect ( Figure 5B ).
Effects of MIP and UP on Trypan Blue Exclusion With Blockade of PKC
The goal of this series of experiments was to determine whether PKC mediated the delayed cardioprotection of MIP and UP. In the presence of 5ϫ10 Ϫ6 mol/L chelerythrine, a PKC inhibitor that by itself had no effect, the cell viability was significantly reduced in both MIP and UP groups ( Figure  6 ) when determined 10 minutes into reperfusion after preconditioning/pretreatment, 20 hours of incubation, and severe MI.
Discussion
The most interesting observations of the present study are (1) blockade of the -OR with selective -OR antagonist nor-BNI obstructed the cardioprotective effects of MIP, and (2) -OR stimulation with specific -OR agonist U50,488H provided similar cardioprotective effects of MIP. The obser- vations indicate that -OR mediates the cardioprotection of MIP. The finding extends the previous observations in our laboratories 11 and other 6, 7 that suggest that OR is involved in cardioprotection of IP. Our results also suggest that neither -nor ␦-OR is involved in the cardioprotection of MIP. The findings are consistent with our previous observations that -OR but not -or ␦-OR is involved in cardiac responses to ischemia/reperfusion. 42 However, the findings are not in agreement with recent reports that suggest that ␦-9,10 but not -OR 43 may be the subtype of OR involved in the cardioprotection of IP. The discrepancies might be related to the animal models and experimental procedures used and the windows studied in different studies.
Results on time-course study showed that there were 2 windows of cardioprotection by UP, which occurred at Ϸ1 hour and 16 to 20 hours, respectively. Similarly, IP produced PKC-inhibitor immediate (1 to 2 hours) 1 and delayed (12 to 72 hours) 2 cardioprotection; however, the length of the window of delayed protection was different from the one we achieved. In the present study, an isolated and cultured myocyte preparation was used, whereas in the previous studies, 1,2 a perfused heart or anesthetized animal model was used.
It has been well established that ischemia causes hypoxia/ anoxia, MI, acidosis, hyperkalemia, and Ca 2ϩ overload in the heart. 44 Ca 2ϩ overload, which is secondary to MI, is one of the most important causes of cell injury during myocardial ischemia. 44, 45 In isolated myocytes, an elevation of extracellular calcium ( 17, 33, 49 in adult rat cardiomyocytes, it is possible that pretreatment with a -OR agonist may produce cardioprotection via alterations of Ca 2ϩ homeostasis in a manner similar to Ca 2ϩ preconditioning. 5, 46 Additional studies are needed to verify this.
Another important finding of the present study is that the delayed cardioprotection of both MIP and UP was attenuated by PKC blockade, which indicates the involvement of PKC. This is consistent with the observations in our laboratories 17 and others 16 that the actions of -OR stimulation involve PKC, presumably via a pertussis toxin-sensitive G-protein and phospholipase C. 33 In fact, PKC is known to activate the ATP-sensitive potassium channel, 50 which has been shown to inhibit the L-type Ca 2ϩ channel and be involved in cardioprotection, and to mediate the cardioprotection of IP. 15 More studies are needed to delineate the signaling pathway of UP.
We used isolated myocytes instead of an isolated heart or in vivo preparations because the model is a simple preparation that would enable us to study the intracellular signaling process, in particular, the Ca 2ϩ response. Results showed that the isolated and cultured myocyte preparation is a useful model to delineate intracellular mechanisms. Like other authors, 41 we used MI for cell pretreatment because it is one of the consequences of ischemia 44, 45 and MIP produces cardioprotection similar to that by IP, 14 presumably because of the well-known cross-tolerance phenomenon.
In the present study, we found that the patterns of change in trypan blue exclusion and rod-shaped cells basically agreed with each other, although the number of nonblue cells was greater than that of rod-shaped cells. Therefore, cell morphology may also be used to confirm the conclusion made on the basis of trypan blue exclusion.
In conclusion, the present study has provided evidence for the first time that -OR may mediate cardioprotection of IP and that PKC and [Ca 2ϩ ] i may be involved in delayed cardioprotection. Additional studies are needed to investigate the importance of [Ca 2ϩ ] i homeostasis and signal-transduction mechanisms in -OR mediated cardioprotection. Ϫ6 mol/L chelerythrine, a PKC antagonist. Experimental procedures used were the same as those in experiments 1 and 2 ( Figure 1A ), except that chelerythrine was administered 1 hour before MIP or UP. CHE-P indicates chelerythrine only; CHEϩMIP, MIP in the presence of chelerythrine; and CHEϩUP, UP in the presence of chelerythrine. Values, which are presented as percentage of nonblue cells divided by the total myocytes counted, are meanϮSEM; nϭ8 cultures of Ϸ200 cells each. **PϽ0.01, ***PϽ0.001 vs VP; ##PϽ0.01 vs the corresponding group without nor-BNI.
